Sobi Q1 2026 report: Strong execution and pipeline momentum
STOCKHOLM, April 28, 2026 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter of 2026. First Quarter 2026 Total revenue increased 24 per cent at CER (constant exchange rates), 11 per cent at actual rates, to SEK 7,184 M (6,465)...
View original →